Neuroscientific Biopharmaceuticals Ltd has released a press release.
Successful Clinical Results Achieved under Special Access
Earlier from Neuroscientific Biopharmaceuticals
- Trading Halt
- Fourth Patient Commences StemSmart MSC Treatment
- 2025 Annual Report & Appendix 4E
- Previous StemSmart Studies Support Renal Transplantation